FlashFlashDetails
Liquidia: Sales exceed expectations, with significant growth in lung disease treatment drugs
2026-08-12 20:43:57
According to CoinMeta, in the financial report released on Wednesday by Liquidia, sales exceeded Wall Street's expectations for the second quarter, and the sales of the lung disease treatment drug Yutrepia grew by double digits. The company performed outstandingly in its competition with United Therapeutics.
Bullish 0
Bearish 0
Source：Internet
This content is for market information only and does not constitute investment advice.
Hot Articles
Refresh
arrow
'No longer a distant place': F2Pool Co-founder Chun Wang joins SpaceX's 2-year mission to Mars
'No longer a distant place': F2Pool Co-founder Chun Wang joins SpaceX's 2-year mission to Mars
05-22 18:25
Polymarket Targets Japan Approval Despite Gambling Laws
Polymarket Targets Japan Approval Despite Gambling Laws
05-22 18:00
ZachXBT flags suspected exploit involving Polymarket's UMA adapter contract on Polygon
ZachXBT flags suspected exploit involving Polymarket's UMA adapter contract on Polygon
05-22 17:57
ZachXBT flags $520K Polymarket exploit on Polygon, team says funds are safe
ZachXBT flags $520K Polymarket exploit on Polygon, team says funds are safe
05-22 17:24
Verus bridge exploiter returns 4,052 ETH, retains $2.8 million bounty: onchain analyst
Verus bridge exploiter returns 4,052 ETH, retains $2.8 million bounty: onchain analyst
05-22 17:24